Paul, Weiss
Jeffrey Osterman
- Deals
- 3
- Latest
- Jun 2026
- Most deals in
- Biotech
Firm
- Paul, Weiss Law firm · 2026 · 3 deals
Often works with
- Krishna Veeraraghavan 3 deals together
- Meggin Bednarczyk 3 deals together
- Chelsea Darnell 2 deals together
- Benjamin Goodchild 2 deals together
- Scott Sontag 2 deals together
- Audrey Paquet 2 deals together
- Peter Fisch 1 deal together
- Ruobing Chen 1 deal together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| Jun 2026 | Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program | Sangamo Therapeutics | Eli Lilly and Company | Asset sale | Legal adviser to Eli Lilly and Company (acquirer) | Completed | – | Biotech+1 | Eli Lilly and Company acquisition of Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program |
| Mar 2026 | Ouro Medicines | – | Gilead | Acquisition | Legal adviser to Galapagos | Announced | 1,675.0 | Biotech+1 | Gilead acquisition of Ouro Medicines |
| Feb 2026 | Orna Therapeutics | – | Eli Lilly and Company | Acquisition | Legal adviser to Eli Lilly and Company (acquirer) | Announced | 2,400.0 | Biotech+1 | Eli Lilly and Company acquisition of Orna Therapeutics |
Deals where Jeffrey Osterman is named on the firm's deal team, by the firm or the press.